Geonomics at Exeter news archive: 2014-2022
Partnership between healthcare professionals and academics in Exeter develops world-first national genetic testing centre.
New research - which studied genomic changes in different types of brain cell - has yielded a potentially surprising result.
A £12.2 million funding boost will help scientists at the University of Exeter and the Royal Devon & Exeter NHS Trust contribute to national efforts to map how COVID-19 spreads and evolves
Scientists and clinicians in Exeter are part of a £20 million investment to unlock the secrets of COVID-19.
A landmark translational research project called the Windows of Hope project, led by researchers from the University of Exeter, has defined more than 150 different genetic disorders in North American Anabaptist (Amish/Mennonite) communities.
A large-scale genomic analysis has revealed some of the inner workings of the body clock, shedding new light on how it links to mental health and disease.
New research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin, Germany, reveals that weight gain between the age of 10 and adulthood is associated with type 2 diabetes (T2D) risk that is independent of body mass index (BMI).
Researchers have found that the genetic causes of rare neurodevelopmental disorders vary more than previously thought.
New research highlights the extent to which epigenetic variation is influenced by both inherited and environmental factors.
Clinicians can match people with type 2 diabetes to the right drug for them to improve control of blood sugar and help avoid damaging side-effects, simply by factoring in simple characteristics such as sex and BMI into prescribing decisions, new research has shown.
A charitable organisation is providing vital funding for people with a rare condition across the world to have genetic screening at the University of Exeter.
New research has shown that the rapid decline in insulin production that causes Type 1 diabetes continues to fall over seven years and then stabilises.
Over a decade, Emma Matthews has progressed from fearing for her son’s life every night to being safe in the knowledge that his diabetes is well managed thanks to the long-term success of “miracle treatment” tablets.
An Exeter clinical scientist who has helped to transform the lives of thousands of patients worldwide has been recognised by the Queen in her latest Birthday Honours.
Having certain genetic variants could explain why people can develop type 1 diabetes at markedly different ages, including later in life, says new University of Exeter research being presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal (11-15 Sept).
The Medical Research Council is awarding more than £1 million to the University of Exeter Medical School to continue their pioneering work into how and why schizophrenia develops.
Identifying cancer links more quickly – genetics project wins European Health Award
Families affected by rare conditions or cancer across the South West are having their genomes sequenced as part of a national research bid.
The University of Exeter has been named as the latest site to deliver Health Education England’s Masters programme in Genomic Medicine.
A free online course led by world-renowned experts at the University of Exeter will offer participants the opportunity to explore how developments in the field of genomics are transforming knowledge and treatment of conditions such as diabetes.
The University of Exeter Medical School has celebrated 20 years of molecular genetics research.
An international research collaboration has shed new light on how DNA sequence variation can influence gene activity in the developing human brain.
A nurse training initiative developed by a team at the University of Exeter Medical School and the Royal Devon and Exeter Hospital to improve diagnosis of monogenic diabetes has won a national award for its contribution to diabetes care.
An international study of nearly 70,000 women has identified more than forty regions of the human genome that are involved in governing at what age a woman goes through the menopause.
Over a 10 year period, the time that babies receive genetic testing after being diagnosed with diabetes has fallen from over four years to under two months.
Cleaning-up post-war explosive chemicals could get cheaper and easier, using a new genetic ‘switch’ device.
A six-year-old boy and his mum and dad today became the first family in the South West to take part in ground-breaking DNA research at the Royal Devon and Exeter NHS Foundation Trust (RD&E), with support from the University, to help fight rare health conditions.
A leading light in genetic diabetes research has been awarded a prestigious national award for outstanding scientists.
New research by scientists at the University of Exeter and King’s College London has made significant progress towards understanding the complex process of prenatal human brain development.
A ground-breaking genomic medicine project, which aims to establish England as a world leader in the fight against cancer and rare disease, will be led in the South West by the Royal Devon & Exeter NHS Foundation Trust (RD&E) working with other health trusts and universities.
A professor who has contributed to significant advances in the understanding of the genetics of diabetes has been named as joint winner of an international prize.
A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family.
Screening for a genetic condition in younger people who are diagnosed with bowel cancer would be cost-effective for the NHS and prevent new cases in them and their relatives, new research has concluded.